Optimization of metoprolol tartrate modified- release matrix tablet formulation using Eudragit NE as binder for metoprolol fluid bed granulation

Main Article Content

Ioan Tomuta
Cristian Alecu
Dana Dudas
Sorin E. Leucuta


The aim of this experimental work was to investigate the possibility of obtaining hydroxypropyl methylcellulose (HPMC) hydrophilic matrix extended-release dosage forms with metoprolol by using aqueous dispersions of Eudragit NE, as
binders in fluid bed granulation. To evaluate the influence of formulation variables (levels of HPMC—Methocel K100 M and Surelease E7 19010) on drug release during a period of time of 12 hours, and on the kinetic release, a full factorial
experimental design with two factors and three levels was used. The formulation factors were the granulation polymer concentration and the matrix-forming polymer concentration. The obtained results have shown that the percentage of the drug released during the 12 hours is influenced both by the Methocel ratio and the Eudragit NE ratio; increasing the ratios of Eudragit and Methocel leads to the decrease of the percentage of the released drug.The influence of Eudragit NE percentage is maximum at four and six hours, but the influence of Methocel K100 M concentration is almost the same at all sampling times; all studied formulations showed a kinetic release that fitted best with the Peppas model.


Download data is not yet available.

Article Details

How to Cite
Tomuta, I., Alecu, C., Dudas, D., & E. Leucuta, S. (2014). Optimization of metoprolol tartrate modified- release matrix tablet formulation using Eudragit NE as binder for metoprolol fluid bed granulation. Asian Journal of Pharmaceutics (AJP), 6(2). https://doi.org/10.22377/ajp.v6i2.62


Siddique S, Khanam J, Bigoniya P. Development of sustained release

capsules containing “coated matrix granules of metoprolol tartrateâ€.

AAPS PharmSciTech 2010;11:1306-14.

Nellore RJ, Rekhi GS, Hussain AS, Tillman LG, Augsburger LL.

Development of metoprolol tartrate extended-release matrix tablet

formulations for regulatory policy consideration. J Control Release


Grassi M, Grassi G. Mathematical modelling and controlled drug

delivery: Matrix systems. Curr Drug Deliv 2005;2:97-6.

Bodea M, Tomuta I, Leucuta SE. Identification of critical formulation

variables for obtaining metoprolol tartrate mini-tablets. Farmacia


Tomuta I, Leucuta SE. The influence of formulation factors on the kinetic

release of metoprolol tartrate from prolong release coated minitablets.

Drug Dev Ind Pharm 2007;33:1071-7.

Vignaduzzo SE, Castellano PM, Kaufman TS. Development and

validation of a dissolution test for meloxicam and pridinolmesylate

from combined tablet formulation. Indian J Pharm Sci 2010;72:197-3.

Golam K, Saiful I, Reza-ul J. Comparative study of aqueous dispersion

of different types of polymers on release behaviour of salbutamol

sulphate from coated pellets. J Pharm Sci Res 2010;2:107-15.

Siepmann F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. Polymer

blends for controlled release coatings. J Control Release 2008;


BaloÄŸlu E, SenyiÄŸit T. A design and evaluation of layered matrix

tablet formulations of metoprolol tartrate. AAPS PharmSciTech

;11:563- 73.

Rasul A, Iqbal M, Murtaza G, Waqas MK, Hanif M, Khan SA, et al. Design,

development and in-vitro evaluation of metoprolol tartrate tablets

containing xanthan-tragacanth. Acta Pol Pharm 2010;67:517-22.

Rekhi GS, Nellore RV, Hussain AS, Tillman LG, Malinowski HJ,

Augsburger LL. Identification of critical formulation and processing

variables for metoprolol tartrate extended-release (ER) matrix tablets.

J Control Release 1999;59:327-42.

Eriksson L, Johansson E, Kettaneh-Wold N, Wikstrom C, Wold S. Design

of Experiments: Principles and Applications. Umea: Umetrics Academy;

Tomut ̆ I, Leucut a SE. Development and in vitro evaluation of

amultiparticulate sustained release carbamazepine formulation. Acta

Pol Pharm Drug Res 1012;69:510-6.

Thakkar VT, Shah PA, Soni TG, Parmar MY, Gohel MC, Gandhi TR.

Goodness-of-fit model-dependent approach for release kinetics

of levofloxacin hemihydrates floating tablet. Dissolut Technol

;16:35- 3.

Sood A, Panchagnula R. Role of dissolution studies in controlled release drug delivery systems. STP Pharma Sci 1999;9:157-68.

Prasacu I, Mircioiu C, Sandulovici R, Enache F, Release of metoprolol

from solid dosage forms. Choice and validation of theoretical model.

Farmacia 2009;LVII:89-98.

Macheras P, Reppas C, Dressman JB. Statistical treatment of

experimental data. In: Biopharmaceutics of orally administered drugs.

Chichester: Ellis Horwood; 1995. p. 260-77.

MODDE 9, Software for Design of Experiments and Optimization: User’s Guide and Tutorial. Umea: Umetrics Academy Inc; 2010.

Shoaib MH, Tazeen J, Merchant HA, Yousuf RI. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC. Pak J Pharm Sci


Siepmann J, Siepmann F. Mathematical modeling of drug delivery. Int J Pharm 2008;364:328-43.

Strübing S, Metz H, Mäder K. Characterization of poly (vinyl acetat)

based floating matrix tablets. J Control Release 2008;126:149-5.